Kalkine Media ASX Share Market News & Research
Sign Up/Login
https://kalkinemedia.com/resources/assets/public/img/flags/au.png AUS
https://kalkinemedia.com/resources/assets/public/img/flags/nz.png NZ
https://kalkinemedia.com/resources/assets/public/img/flags/uk.png UK
https://kalkinemedia.com/resources/assets/public/img/flags/ca.png CA
https://kalkinemedia.com/resources/assets/public/img/flags/us.png USA
https://kalkinemedia.com/resources/assets/public/img/flags/fr.png FRA
https://kalkinemedia.com/resources/assets/public/img/flags/de.png GER
https://kalkinemedia.com/resources/assets/public/img/flags/es.png ESP
https://kalkinemedia.com/resources/assets/public/img/flags/it.png ITA
https://kalkinemedia.com/resources/assets/public/img/flags/nl.png NLD
https://kalkinemedia.com/resources/assets/public/img/flags/pt.png PRT
https://kalkinemedia.com/resources/assets/public/img/flags/se.png SWE
https://kalkinemedia.com/resources/assets/public/img/flags/gr.png GRC
https://kalkinemedia.com/resources/assets/public/img/flags/in.png IND
https://kalkinemedia.com/resources/assets/public/img/flags/pl.png POL
https://kalkinemedia.com/resources/assets/public/img/flags/br.png BRA
https://kalkinemedia.com/resources/assets/public/img/flags/za.png ZAF
https://kalkinemedia.com/resources/assets/public/img/flags/ru.png RUS
https://kalkinemedia.com/resources/assets/public/img/flags/cn.png CHN
https://kalkinemedia.com/resources/assets/public/img/flags/ae.png UAE
Kalkine Media ASX Share Market News & Research
  1. Home
  2. Companies
  3. Healthcare
  4. Noxopharm Limited

Noxopharm Ltd (ASX:NOX)

Healthcare

*All values are in AUD

AUD 0.13 0.005 (4%)

(As on 2024-10-30T00:13:00Z UTC )
Previous Close
0.13
Open
0.13
Close
0.13
Dividend Yield
0.000%
Share Price & News

DAY RANGE

0.13 L 0.13 H
Income Statement Balance Sheet Cash Flow Statement

Income Statement

Balance Sheet

Cash Flow Statement

Disclaimer

* Data powered by EODHD®. Data delayed 20 minutes unless otherwise indicated.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.